ParaGen Technologies, the Columbus, OH-based parent company of four medical device companies, closed a $3m bridge funding round.
Led by Ross Kayuha, CEO, ParaGen operates four portfolio companies — RenovoDerm, Atreon Orthopedics, Vascular Genesis and Tarian Medical, which are building product lines for wound care, orthopedic, peripheral vascular and hernia markets respectively.
The funding will be used to commercialize RenovoDerm’s proprietary product The Phoenix Wound MatrixTM, pre-testing for FDA clearance of Tarian Medical’s Tarian AbS, as well as beginning the final round of animal testing for Vascular Genesis’ vascular access graft product.
ParaGen Technologies is a joint venture between Nanofiber Solutions, which developed the core technology, and the Ikove Startup Nursery, which provided the funding and go-to-market strategy.
In mid-2019, ParaGen and Ikove plan to raise the company’s first Series A round.
FinSMEs
29/11/2018